Literature DB >> 3390181

Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes.

U Mrowietz1, J M Schröder, E Christophers.   

Abstract

Preparations of recombinant human tumor necrosis factor alpha (rhuTNF alpha) free of aminoterminal methionine were tested for human neutrophil granulocyte (PMN) and monocyte (MO) chemotactic activity using the Boyden chamber system. Over a wide range of concentrations (10(-7)-10(-15) M) rhuTNF alpha of two different sources failed to elicit chemotactic responses in PMN or MO, whereas strong PMN and MO chemotactic activity could be detected using the tripeptide N-formyl-methionyl-leucyl-phenylalanine (FMLP). In addition, rhuTNF alpha containing 62% aminoterminal methionine failed to induce PMN and MO chemotaxis. It is concluded that rhuTNF alpha may not be a chemotaxin for human PMN and MO in vitro.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390181     DOI: 10.1016/s0006-291x(88)81358-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes.

Authors:  J M Wang; S Walter; A Mantovani
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

2.  Endotoxin-stimulated human macrophages produce a factor that induces polymorphonuclear leucocyte infiltration and is distinct from interleukin-1, tumour necrosis factor alpha and chemotactic factors.

Authors:  P Megyeri; J Sadowska; T B Issekutz; A C Issekutz
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms.

Authors:  L H Faccioli; G E Souza; F Q Cunha; S Poole; S H Ferreira
Journal:  Agents Actions       Date:  1990-06

4.  Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat.

Authors:  J S Warren; K R Yabroff; D G Remick; S L Kunkel; S W Chensue; R G Kunkel; K J Johnson; P A Ward
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

5.  Infiltration of neutrophils by intrapleural injection of tumour necrosis factor, interleukin-1, and interleukin-8 in rats, and its modification by actinomycin D.

Authors:  I Utsunomiya; M Ito; K Watanabe; S Tsurufuji; K Matsushima; S Oh
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

6.  Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils.

Authors:  François Niyonsaba; Hideoki Ogawa; Isao Nagaoka
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

7.  Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.

Authors:  S Nagao; M Nakanishi; H Kutsukake; K Yagawa; S Kusumoto; T Shiba; A Tanaka; S Kotani
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 8.  Peptides and cytokines.

Authors:  J M Schröder
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

9.  Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.

Authors:  M S Bajaj; R R Kew; R O Webster; T M Hyers
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

10.  Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-alpha in the rat.

Authors:  J L Wright; R E Merchant
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.